Artículos de revistas sobre el tema "Carbonyl reductase 1 (CBR1)"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Carbonyl reductase 1 (CBR1)".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Varatharajan, Savitha, Ajay Abraham, Shaji R. Velayudhan, Rayaz Ahmed, Aby Abraham, Biju George, Mammen Chandy, Alok Srivastava, Vikram Mathews y Poonkuzhali Balasubramanian. "Carbonyl Reductase 1 Expression and Polymorphisms Influence Daunorubicin Metabolism in AML". Blood 118, n.º 21 (18 de noviembre de 2011): 2484. http://dx.doi.org/10.1182/blood.v118.21.2484.2484.
Texto completoBlanco, Javier G., Can-Lan Sun, Wendy Landier, Lu Chen, Diego Esparza-Duran, Wendy Leisenring, Allison Mays et al. "Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group". Journal of Clinical Oncology 30, n.º 13 (1 de mayo de 2012): 1415–21. http://dx.doi.org/10.1200/jco.2011.34.8987.
Texto completoHu, Dawei, Namiki Miyagi, Yuki Arai, Hiroaki Oguri, Takeshi Miura, Toru Nishinaka, Tomoyuki Terada et al. "Synthesis of 8-hydroxy-2-iminochromene derivatives as selective and potent inhibitors of human carbonyl reductase 1". Organic & Biomolecular Chemistry 13, n.º 27 (2015): 7487–99. http://dx.doi.org/10.1039/c5ob00847f.
Texto completoVyskočilová, Erika, Barbora Szotáková, Lenka Skálová, Hana Bártíková, Jitka Hlaváčová y Iva Boušová. "Age-Related Changes in Hepatic Activity and Expression of Detoxification Enzymes in Male Rats". BioMed Research International 2013 (2013): 1–10. http://dx.doi.org/10.1155/2013/408573.
Texto completoBell, Rachel, Elisa Villalobos, Mark Nixon, Allende Miguelez-Crespo, Matthew Sharp, Martha Koerner, Emma Allan et al. "Carbonyl Reductase 1 Overexpression in Adipose Amplifies Local Glucocorticoid Action and Impairs Glucose Tolerance in Lean Mice". Journal of the Endocrine Society 5, Supplement_1 (1 de mayo de 2021): A806. http://dx.doi.org/10.1210/jendso/bvab048.1639.
Texto completoWaclawik, Agnieszka y Adam J. Ziecik. "Differential expression of prostaglandin (PG) synthesis enzymes in conceptus during peri-implantation period and endometrial expression of carbonyl reductase/PG 9-ketoreductase in the pig". Journal of Endocrinology 194, n.º 3 (septiembre de 2007): 499–510. http://dx.doi.org/10.1677/joe-07-0155.
Texto completoGuo, Chunming, Wangsheng Wang, Chao Liu, Leslie Myatt y Kang Sun. "Induction of PGF2α Synthesis by Cortisol Through GR Dependent Induction of CBR1 in Human Amnion Fibroblasts". Endocrinology 155, n.º 8 (1 de agosto de 2014): 3017–24. http://dx.doi.org/10.1210/en.2013-1848.
Texto completoFerguson, Daniel C., Qiuying Cheng y Javier G. Blanco. "Characterization of the Canine Anthracycline-Metabolizing Enzyme Carbonyl Reductase 1 (cbr1) and the Functional Isoform cbr1 V218". Drug Metabolism and Disposition 43, n.º 7 (27 de abril de 2015): 922–27. http://dx.doi.org/10.1124/dmd.115.064295.
Texto completoMadadi Mahani, Nosrat, Alireaza Mohadesi Zarandi y Azra Horzadeh. "QSAR studies of novel iminochromene derivatives as as carbonyl reductase 1 (CBR1) inhibito". Marmara Pharmaceutical Journal 22, n.º 2 (6 de abril de 2018): 227–36. http://dx.doi.org/10.12991/mpj.2018.60.
Texto completoMiura, Takeshi, Ayako Taketomi, Toru Nishinaka y Tomoyuki Terada. "Regulation of human carbonyl reductase 1 (CBR1, SDR21C1) gene by transcription factor Nrf2". Chemico-Biological Interactions 202, n.º 1-3 (febrero de 2013): 126–35. http://dx.doi.org/10.1016/j.cbi.2012.11.023.
Texto completoArai, Yuki, Satoshi Endo, Namiki Miyagi, Naohito Abe, Takeshi Miura, Toru Nishinaka, Tomoyuki Terada et al. "Structure–activity relationship of flavonoids as potent inhibitors of carbonyl reductase 1 (CBR1)". Fitoterapia 101 (marzo de 2015): 51–56. http://dx.doi.org/10.1016/j.fitote.2014.12.010.
Texto completoGonzalez-Covarrubias, Vanessa, Jianping Zhang, James L. Kalabus, Mary V. Relling y Javier G. Blanco. "Pharmacogenetics of Human Carbonyl Reductase 1 (CBR1) in Livers from Black and White Donors". Drug Metabolism and Disposition 37, n.º 2 (20 de noviembre de 2008): 400–407. http://dx.doi.org/10.1124/dmd.108.024547.
Texto completoJang, Miran y Sung Soo Kim. "Inhibition of Carbonyl Reductase 1(CBR1) Enhances Arsenic Trioxide-mediated Apoptosis in Leukemia Cells". Free Radical Biology and Medicine 49 (enero de 2010): S63. http://dx.doi.org/10.1016/j.freeradbiomed.2010.10.148.
Texto completoQuiñones-Lombraña, Adolfo, Qiuying Cheng, Daniel C. Ferguson y Javier G. Blanco. "Transcriptional regulation of the canine carbonyl reductase 1 gene ( cbr1 ) by the specificity protein 1 (Sp1)". Gene 592, n.º 1 (octubre de 2016): 209–14. http://dx.doi.org/10.1016/j.gene.2016.08.005.
Texto completoGonzalez-Covarrubias, Vanessa, James L. Kalabus y Javier G. Blanco. "Inhibition of Polymorphic Human Carbonyl Reductase 1 (CBR1) by the Cardioprotectant Flavonoid 7-monohydroxyethyl Rutoside (monoHER)". Pharmaceutical Research 25, n.º 7 (1 de mayo de 2008): 1730–34. http://dx.doi.org/10.1007/s11095-008-9592-5.
Texto completoCheng, Q., C. Sanborn, D. Ferguson y J. G. Blanco. "Short Communication DNA sequence variants in the carbonyl reductase 1 (cbr1) gene in seven breeds of Canis lupus familiaris". Genetics and Molecular Research 11, n.º 2 (2012): 1109–16. http://dx.doi.org/10.4238/2012.april.27.10.
Texto completoGonzalez-Covarrubias, Vanessa, Debashis Ghosh, Sukhwinder S. Lakhman, Lakshmi Pendyala y Javier G. Blanco. "A Functional Genetic Polymorphism on Human Carbonyl Reductase 1 (CBR1 V88I) Impacts on Catalytic Activity and NADPH Binding Affinity". Drug Metabolism and Disposition 35, n.º 6 (7 de marzo de 2007): 973–80. http://dx.doi.org/10.1124/dmd.107.014779.
Texto completoKalabus, James L., Qiuying Cheng y Javier G. Blanco. "MicroRNAs Differentially Regulate Carbonyl Reductase 1 (CBR1) Gene Expression Dependent on the Allele Status of the Common Polymorphic Variant rs9024". PLoS ONE 7, n.º 11 (1 de noviembre de 2012): e48622. http://dx.doi.org/10.1371/journal.pone.0048622.
Texto completoLakhman, Sukhwinder S., Xiaomin Chen, Vanessa Gonzalez-Covarrubias, Erin G. Schuetz y Javier G. Blanco. "Functional Characterization of the Promoter of Human Carbonyl Reductase 1 (CBR1). Role of XRE Elements in Mediating the Induction of CBR1 by Ligands of the Aryl Hydrocarbon Receptor". Molecular Pharmacology 72, n.º 3 (14 de junio de 2007): 734–43. http://dx.doi.org/10.1124/mol.107.035550.
Texto completoSeliger, Jan Moritz, Hans-Jörg Martin, Edmund Maser y Jan Hintzpeter. "Potent inhibition of human carbonyl reductase 1 (CBR1) by the prenylated chalconoid xanthohumol and its related prenylflavonoids isoxanthohumol and 8-prenylnaringenin". Chemico-Biological Interactions 305 (mayo de 2019): 156–62. http://dx.doi.org/10.1016/j.cbi.2019.02.031.
Texto completoJordheim, Lars-Petter, Vincent Ribrag, Herve Ghesquieres, Sophie Pallardy, Richard Delarue, Herve Tilly, Corinne Haioun, Fabrice Jardin, Gilles Salles y Charles Dumontet. "Single Nucleotide Polymorphisms in ABCB1 and CBR1 Predict Toxicity to R-CHOP Type Regimens in Patients with Diffuse Non Hodgkin's Lymphoma". Blood 120, n.º 21 (16 de noviembre de 2012): 1616. http://dx.doi.org/10.1182/blood.v120.21.1616.1616.
Texto completoKalabus, James L., Qiuying Cheng, Raqeeb G. Jamil, Erin G. Schuetz y Javier G. Blanco. "Induction of carbonyl reductase 1 (CBR1) expression in human lung tissues and lung cancer cells by the cigarette smoke constituent benzo[a]pyrene". Toxicology Letters 211, n.º 3 (junio de 2012): 266–73. http://dx.doi.org/10.1016/j.toxlet.2012.04.006.
Texto completoDocherty, Anna R., Arden Moscati, Tim B. Bigdeli, Alexis C. Edwards, Roseann E. Peterson, Daniel E. Adkins, John S. Anderson, Jonathan Flint, Kenneth S. Kendler y Silviu-Alin Bacanu. "Pathway-based polygene risk for severe depression implicates drug metabolism in CONVERGE". Psychological Medicine 50, n.º 5 (2 de abril de 2019): 793–98. http://dx.doi.org/10.1017/s0033291719000618.
Texto completoFan, L., J. Y. Guo, C. I. Wong, R. Lim, H. L. Yap, Y. M. Khoo, P. Iau, B. C. Goh, H. S. Lee y S. C. Lee. "Genetic variants in human carbonyl reductase 3 (CBR3) and their influence on doxorubicin pharmacokinetics in Asian breast cancer patients". Journal of Clinical Oncology 25, n.º 18_suppl (20 de junio de 2007): 2505. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.2505.
Texto completoSantana, Sanzio, Thassila Nogueira Pitanga, Jeanne Machado de Santana, Dalila Lucíola Zanette, Corynne Stephanie A. Adanho, Nívea Farias Luz, Valéria Matos Borges y Marilda Souza Goncalves. "Hydroxyurea Exhibits Antioxidant Activity Via the Nrf2 Pathway- Antioxidant/Electrophile Response Element Regulated By p62/ SQSTM1". Blood 132, Supplement 1 (29 de noviembre de 2018): 3648. http://dx.doi.org/10.1182/blood-2018-99-117220.
Texto completoBudik, S., I. Walter, R. Ertl y C. Aurich. "Detection of Carbonyl Reductase-1 (CBR-1) enzyme in pre-implantation equine conceptuses and its putative role in embryo mobility". Journal of Equine Veterinary Science 89 (junio de 2020): 103065. http://dx.doi.org/10.1016/j.jevs.2020.103065.
Texto completoZhou, Yumin, Man Wang, Weiyan Yang, Jianjun Li, Jialin Li, Yueying Hu, Wei Wang, Chunli Che y Hong Qi. "Environmental and Genetic Factors in the Pathogenesis of COPD in the Road-Working Population". Disease Markers 2021 (29 de abril de 2021): 1–10. http://dx.doi.org/10.1155/2021/9953234.
Texto completoGaudy, Allison, Gerald J. Fetterly, Alex A. Adjei, Tracey L. O'Connor, Adolfo Quinones, Javier G. Blanco, Daniel Ferguson, Patricia D. Meholick y James Kalabus. "Investigation of the pharmacogenetic influences of carbonyl reductase on doxorubicin and doxorubicinol in breast cancer patients." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): 2594. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.2594.
Texto completoElsayed, Abdelrahman H., Huiyun Wu, Xueyuan Cao, Susana C. Raimondi, James R. Downing, Raul Ribeiro, Tanja A. Gruber et al. "A 5-Gene Ara-C, Daunorubicin and Etoposide (ADE) Drug Response Score As a Prognostic Tool to Predict AML Treatment Outcome". Blood 134, Supplement_1 (13 de noviembre de 2019): 1429. http://dx.doi.org/10.1182/blood-2019-128787.
Texto completoLarkin, Trisha, Abdelrahman H. Elsayed, Roya Rafiee, Natasha Emanuel, Beate Greer, Biljana N. Horn y Jatinder K. Lamba. "Identification of Pharmacogenomic Single Nucleotide Polymorphism Variants As Contributors to Toxicity Phenotype in the Treatment of Acute Childhood Leukemia". Blood 136, Supplement 1 (5 de noviembre de 2020): 25–26. http://dx.doi.org/10.1182/blood-2020-143195.
Texto completoBateman, Raynard L., Daniel Rauh, Brandon Tavshanjian y Kevan M. Shokat. "Human Carbonyl Reductase 1 Is anS-Nitrosoglutathione Reductase". Journal of Biological Chemistry 283, n.º 51 (29 de septiembre de 2008): 35756–62. http://dx.doi.org/10.1074/jbc.m807125200.
Texto completoMiura, Takeshi, Toru Nishinaka y Tomoyuki Terada. "Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1". Molecular and Cellular Biochemistry 315, n.º 1-2 (21 de mayo de 2008): 113–21. http://dx.doi.org/10.1007/s11010-008-9794-5.
Texto completoAplenc, R., J. Blanco, W. Leisenring, S. Davies, M. Relling, L. Robison, C. Sklar, M. Stovall y S. Bhatia. "Polymorphisms in candidate genes in patients with congestive heart failure (CHF) after childhood cancer: A Report from the Childhood Cancer Survivor Study (CCSS)". Journal of Clinical Oncology 24, n.º 18_suppl (20 de junio de 2006): 9004. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.9004.
Texto completoWayne, Laura L. y John Browse. "Homologous electron transport components fail to increase fatty acid hydroxylation in transgenic Arabidopsis thaliana". F1000Research 2 (4 de octubre de 2013): 203. http://dx.doi.org/10.12688/f1000research.2-203.v1.
Texto completoWayne, Laura L. y John Browse. "Homologous electron transport components fail to increase fatty acid hydroxylation in transgenic Arabidopsis thaliana". F1000Research 2 (13 de noviembre de 2013): 203. http://dx.doi.org/10.12688/f1000research.2-203.v2.
Texto completoBoušová, Iva, Lenka Skálová, Pavel Souček y Petra Matoušková. "The modulation of carbonyl reductase 1 by polyphenols". Drug Metabolism Reviews 47, n.º 4 (29 de septiembre de 2015): 520–33. http://dx.doi.org/10.3109/03602532.2015.1089885.
Texto completoCarlquist, Magnus, Torbjörn Frejd y Marie F. Gorwa-Grauslund. "Flavonoids as inhibitors of human carbonyl reductase 1". Chemico-Biological Interactions 174, n.º 2 (julio de 2008): 98–108. http://dx.doi.org/10.1016/j.cbi.2008.05.021.
Texto completoKassner, Nina, Klaus Huse, Hans-Jörg Martin, Ute Gödtel-Armbrust, Annegret Metzger, Ingolf Meineke, Jürgen Brockmöller et al. "Carbonyl Reductase 1 Is a Predominant Doxorubicin Reductase in the Human Liver". Drug Metabolism and Disposition 36, n.º 10 (17 de julio de 2008): 2113–20. http://dx.doi.org/10.1124/dmd.108.022251.
Texto completoTang, Xianqing, Peiqiang Mu, Jun Wu, Jun Jiang, Caihui Zhang, Ming Zheng y Yiqun Deng. "Carbonyl Reduction of Mequindox by Chicken and Porcine Cytosol and Cloned Carbonyl Reductase 1". Drug Metabolism and Disposition 40, n.º 4 (19 de enero de 2012): 788–95. http://dx.doi.org/10.1124/dmd.111.043547.
Texto completoMoschini, Roberta, Rossella Rotondo, Giovanni Renzone, Francesco Balestri, Mario Cappiello, Andrea Scaloni, Umberto Mura y Antonella Del-Corso. "Kinetic features of carbonyl reductase 1 acting on glutathionylated aldehydes". Chemico-Biological Interactions 276 (octubre de 2017): 127–32. http://dx.doi.org/10.1016/j.cbi.2017.03.003.
Texto completoShi, Sophia M. y Li Di. "The role of carbonyl reductase 1 in drug discovery and development". Expert Opinion on Drug Metabolism & Toxicology 13, n.º 8 (27 de julio de 2017): 859–70. http://dx.doi.org/10.1080/17425255.2017.1356820.
Texto completoVaratharajan, Savitha, Ajay Abraham, Wei Zhang, R. V. Shaji, Rayaz Ahmed, Aby Abraham, Biju George et al. "Carbonyl reductase 1 expression influences daunorubicin metabolism in acute myeloid leukemia". European Journal of Clinical Pharmacology 68, n.º 12 (5 de mayo de 2012): 1577–86. http://dx.doi.org/10.1007/s00228-012-1291-9.
Texto completoRamsden, Diane, Dustin Smith, Raquel Arenas, Kosea Frederick y Matthew A. Cerny. "Identification and Characterization of a Selective Human Carbonyl Reductase 1 Substrate". Drug Metabolism and Disposition 46, n.º 10 (1 de agosto de 2018): 1434–40. http://dx.doi.org/10.1124/dmd.118.082487.
Texto completoMoschini, Roberta, Giovanni Renzone, Vito Barracco, Mario Cappiello, Andrea Scaloni, Francesco Balestri, Umberto Mura y Antonella Del-Corso. "A new role for Carbonyl Reductase 1 on 4-hydroxynonenal detoxification". Free Radical Biology and Medicine 124 (agosto de 2018): 572. http://dx.doi.org/10.1016/j.freeradbiomed.2018.05.047.
Texto completoHintzpeter, Jan, Jan Hornung, Bettina Ebert, Hans-Jörg Martin y Edmund Maser. "Curcumin is a tight-binding inhibitor of the most efficient human daunorubicin reductase – Carbonyl reductase 1". Chemico-Biological Interactions 234 (junio de 2015): 162–68. http://dx.doi.org/10.1016/j.cbi.2014.12.019.
Texto completoBarracco, Vito, Roberta Moschini, Giovanni Renzone, Mario Cappiello, Francesco Balestri, Andrea Scaloni, Umberto Mura y Antonella Del-Corso. "Dehydrogenase/reductase activity of human carbonyl reductase 1 with NADP(H) acting as a prosthetic group". Biochemical and Biophysical Research Communications 522, n.º 1 (enero de 2020): 259–63. http://dx.doi.org/10.1016/j.bbrc.2019.11.090.
Texto completoBiswas, Md Sanaullah, Ryota Terada y Jun’ichi Mano. "Inactivation of Carbonyl-Detoxifying Enzymes by H2O2 Is a Trigger to Increase Carbonyl Load for Initiating Programmed Cell Death in Plants". Antioxidants 9, n.º 2 (6 de febrero de 2020): 141. http://dx.doi.org/10.3390/antiox9020141.
Texto completoAlshogran, Osama, Bradley Urquhart y Thomas Nolin. "Downregulation of Hepatic Carbonyl Reductase Type 1 in End-Stage Renal Disease". Drug Metabolism Letters 9, n.º 2 (27 de octubre de 2015): 111–18. http://dx.doi.org/10.2174/1872312809666150818111626.
Texto completoLu, Yuan, Wen Liu, Ting Lv, Yanli Wang, Ting Liu, Yi Chen, Yang Jin et al. "Aidi injection reduces doxorubicin-induced cardiotoxicity by inhibiting carbonyl reductase 1 expression". Pharmaceutical Biology 60, n.º 1 (18 de agosto de 2022): 1616–24. http://dx.doi.org/10.1080/13880209.2022.2110127.
Texto completoOSAWA, YUKI, YOSHIHITO YOKOYAMA, TATSUHIKO SHIGETO, MASAYUKI FUTAGAMI y HIDEKI MIZUNUMA. "Decreased expression of carbonyl reductase 1 promotes ovarian cancer growth and proliferation". International Journal of Oncology 46, n.º 3 (30 de diciembre de 2014): 1252–58. http://dx.doi.org/10.3892/ijo.2014.2810.
Texto completo